Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session 2

3958 - Quality of Life (QoL) in Metastatic Colorectal Cancer (mCRC) in the Real World: Final Results of a European Survey


29 Sep 2019


Poster Display session 2


Tumour Site

Colon and Rectal Cancer


Zorana Maravic


Annals of Oncology (2019) 30 (suppl_5): v198-v252. 10.1093/annonc/mdz246


Z. Maravic1, I.M. Rawicka2, L. Lemmens3, A. Benedict4, P. Rakonczai4, K. Komlos5

Author affiliations

  • 1 Europacolon, Digestive Cancers Europe, 3090 - Overijse/BE
  • 2 Europacolon Poland, EuropaColon Polska, 05-400 - Otwock/PL
  • 3 Health Education, COPE-unlimited, 351 - Kermt/BE
  • 4 Modelling And Simulation, Evidera Inc., 1022 - Budapest/HU
  • 5 Anaesthesiology And Intensive Therapy, Semmelweis University, 1085 - Budapest/HU


Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 3958


Digestive Cancers Europe (DiCE), a European digestive cancer patients umbrella organization, planned and executed a cross-sectional survey in 15 European countries on the Unmet Needs of Patients Living with mCRC to examine the challenges and needs and QoL of those living with mCRC.


DiCE partner organisations, together with clinicians and nurses recruited patients for the survey (paper-based and online). The survey included demographics, data on discovery of the disease, diagnosis and treatment and the EORTC QLQ-C30 and CR29. Single data entry from the paper surveys was done by DiCE. Descriptive statistics and regression analyses were run to examine the global QoL score, function (F) - and symptom-specific scores, the item on financial difficulties and CR29 scores and their association with patient and disease characteristics and care setting by country and overall.


883 surveys from Austria, Belgium, Cyprus (CY), Germany, Hungary (HU), Italy, Netherlands (NL), Norway, Serbia (RS), Poland, Spain (SP), UK, Portugal, Turkey and Ireland were collected. Only 8 countries with samples over 35 were analyzed on their own. Completion rates across QoL items were high (91-94%). Large variation across countries have been observed in mean scores (Table). Eastern vs Western Europe contrasted sharply, with Serbia and Poland reporting lower functional and much higher symptom scores for fatigue, nausea, vomiting, pain and insomnia. Regression analyses indicated that after adjustment for age, gender and care setting country differences remained significant. Patterns in results across dimensions of EORTC QLQ-CR29 were similar.Table:


Mean (SD)Global QoLPhysical FRole FEmotional FCognitive FSocial F
Lowest score55.94 (21.10) RS69.06 (23.93) CY62.58 (34.73) CY53.51 (28.35) RS71.31 (24.6) RS54.04 (25.91) RS
Highest score69.26 (20.68) HU84.29 (17.87) SP81.76 (25.41) SP80.92 (21.04) NL87.86 (19.13) HU80.91 (24.63) HU
OVERALL62.02 (21.75)74.25 (20.85)71.41 (28.76)68.25 (26.41)78.58 (23.39)68.56 (28.99)


Country specific mean QoL scores in all function/symptom dimensions varied greatly across countries. This study indicates that care setting and other country-specific circumstances have important associations to QoL. Real-world mCRC patients’ QoL may be lower than those recruited in clinical trials.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

EuropaColon / Digestive Cancers Europe.


Merck, BMS, Sandoz and Sirtex.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.